Marisa R. Buchakjian
Papers
3
Total Citations
18
H-Index
2
About
Marisa R. Buchakjian is a surgical oncologist and head and neck cancer researcher whose work focuses on optimizing treatment strategies for squamous cell carcinomas of the upper aerodigestive tract. Her research centers on the critical interplay between primary treatment modality—comparing definitive radiotherapy versus partial laryngectomy or robotic-assisted surgery—and patient outcomes in early-stage supraglottic and oropharyngeal cancers. Buchakjian’s most cited study (2021, 11 citations) examined whether radiotherapy or partial laryngectomy with elective neck dissection yields superior results for T1-2, N0 supraglottic squamous cell carcinoma, providing evidence to guide single-modality treatment decisions. Her 2023 work (6 citations) made a notable contribution by investigating how preoperative core needle biopsy may artifactually induce extranodal extension in HPV-associated oropharyngeal cancer—a finding with direct implications for adjuvant treatment escalation decisions. Additionally, her 2022 study explored how HPV status influences outcomes when comparing radiotherapy to robotic surgery for early oropharyngeal cancer. Through these clinically impactful investigations, Buchakjian is helping to refine personalized treatment algorithms that balance oncologic control with functional preservation for patients with head and neck malignancies.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3